XML 10 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 9,811,673 $ 14,764,346
Accounts receivable, net 1,091,729 943,272
Accounts receivable, related party net 0  
Prepaid expenses and other current assets 478,218 375,360
Inventories 1,551,842 1,541,513
Advances on contracts 1,581,483 1,309,260
Total current assets 14,514,945 18,933,751
Furniture, fixtures and equipment, net 17,401 23,713
Intangibles, net 237,636 277,619
Right of use assets 484,327 550,511
Other assets 24,150 24,150
Total assets 15,278,459 19,809,744
Current liabilities:    
Accounts payable 1,282,721 780,428
Accounts payable, related party 910,999 395,857
Accrued expenses and other payables 1,050,173 1,417,248
Accrued expenses, related party 333,483 414,241
Current portion of finance lease liabilities 9,153 8,545
Current portion of operating lease liabilities 88,933 81,001
Total current liabilities 3,675,462 3,097,320
Non-current portion of finance lease liabilities 13,120 20,062
Non-current portion of operating lease liabilities 408,998 476,980
Total liabilities 4,097,580 3,594,362
Commitments
Stockholders’ equity    
Common stock, par value $.001; authorized 100,000,000 shares; 68,907,394 and 68,153,336 shares issued on September 30, 2022, and December 31, 2021, and 68,874,061 and 68,120,003, shares outstanding as September 30, 2022, and December 31, 2021. 68,907 68,153
Additional paid in capital 126,666,340 124,915,560
Accumulated deficit (114,436,281) (107,704,274)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific, Inc. stockholders' equity 11,387,450 16,367,923
Noncontrolling interest (206,571) (152,541)
Total stockholders’ equity 11,180,879 16,215,382
Total liabilities and stockholders’ equity $ 15,278,459 $ 19,809,744